About the Sinovac, Sputnik V and Johnson & Johnson Covid-19 vaccines

An inactivated adenovirus is used as the vector to deliver the gene for the SARS-CoV-2 spike protein into the body in the Sinovac, Sputnik V, and Johnson and Johnson Covid-19 vaccines. — Wikimedia Commons

The efficacy of the Sinovac vaccine (officially named CoronaVac, but more popularly known by the name of its developer Beijing-based biopharmaceutical company Sinovac Biotech Limited) has been found to be to be 50.4% in preventing symptomatic Covid-19 by researchers in Brazil.

The director of the Chinese Center for Disease Control and Prevention himself has said that “Chinese vaccines don’t have very high protection rates”, and that the Chinese government is considering mixing the vaccines to give their efficacy a boost.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Health

When your shortness of breath is in your head
Are physically-demanding jobs a risk for dementia?
The financial impact of having a stroke
Updated Covid-19 vaccines for 2023-24 approved by US FDA
Long Covid study to look at treatment options for various symptoms
Here's when to expect your baby’s teeth
Big Pharma could affect Big Food with obesity drugs, says Big Finance
Futureproofing cancer centres with talent and technology
Boost your chance of pregnancy with a urine ovulation test
Can uterine fibroids affect my chances of getting pregnant?

Others Also Read